CABOZANTINIB S-MALATE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where CABOZANTINIB S-MALATE was used for Psoriasis.
Most Reported Side Effects for CABOZANTINIB S-MALATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 8,282 | 21.1% | 315 | 1,313 |
| Fatigue | 6,819 | 17.4% | 261 | 897 |
| Off label use | 5,245 | 13.4% | 591 | 633 |
| Nausea | 4,341 | 11.1% | 175 | 736 |
| Decreased appetite | 4,076 | 10.4% | 233 | 751 |
| Blood pressure increased | 2,939 | 7.5% | 63 | 416 |
| Malignant neoplasm progression | 2,718 | 6.9% | 909 | 626 |
| Palmar-plantar erythrodysaesthesia syndrome | 2,706 | 6.9% | 119 | 349 |
| Weight decreased | 2,657 | 6.8% | 139 | 462 |
| Stomatitis | 2,560 | 6.5% | 91 | 347 |
| Death | 2,504 | 6.4% | 2,497 | 368 |
| Constipation | 2,098 | 5.3% | 91 | 359 |
| Blister | 1,943 | 5.0% | 27 | 150 |
| Vomiting | 1,870 | 4.8% | 113 | 491 |
| Taste disorder | 1,851 | 4.7% | 43 | 236 |
Other Indications for CABOZANTINIB S-MALATE
Renal cancer (15,186)
Renal cell carcinoma (9,156)
Product used for unknown indication (3,104)
Hepatocellular carcinoma (2,670)
Thyroid cancer (1,615)
Metastatic renal cell carcinoma (1,055)
Metastases to lung (727)
Clear cell renal cell carcinoma (704)
Metastases to bone (514)
Hepatic cancer (508)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)